División de Gastroenterología, Hospital Regional ISSSTE, Culiacán, Sinaloa 80230, México.
World J Gastroenterol. 2010 Oct 7;16(37):4685-90. doi: 10.3748/wjg.v16.i37.4685.
To determine the possible association of the ApoB-100 (XbaI), ApoE (HhaI) and CYP7A1 (BsaI) gene polymorphisms, with the development of cholesterol gallstone disease (GD) in a Mexican population.
The polymorphisms were analyzed by polymerase chain reaction followed by restriction fragment length polymorphism, in two groups matched by ethnicity, age and sex: patients with GD (n = 101) and stone-free control subjects (n = 101).
Allelic frequencies in patients and controls were: 34.16% vs 41.58% (P = 0.124) for X+ of ApoB-100; 4.46% vs 5.94% (P = 0.501) for E2, 85.64% vs 78.22% (P = 0.052) for E3, 9.90% vs 15.84% (P = 0.075) for E4 of ApoE; and 25.74% vs 27.72% (P = 0.653) for C of CYP7A1. Differences in genotypic frequencies between the studied groups were not significant (P < 0.05).
These results demonstrated that no association exists between the studied polymorphisms and cholelithiasis in this high prevalent population.
确定载脂蛋白 B-100(XbaI)、载脂蛋白 E(HhaI)和 CYP7A1(BsaI)基因多态性与胆固醇胆囊结石病(GD)在墨西哥人群中的发展之间可能存在的关联。
通过聚合酶链反应(PCR)后限制性片段长度多态性分析,在两组按种族、年龄和性别匹配的患者中:GD 患者(n=101)和无结石对照组(n=101)。
患者和对照组的等位基因频率分别为:ApoB-100 的 X+为 34.16%对 41.58%(P=0.124);ApoE 的 E2 为 4.46%对 5.94%(P=0.501),E3 为 85.64%对 78.22%(P=0.052),E4 为 9.90%对 15.84%(P=0.075);CYP7A1 的 C 为 25.74%对 27.72%(P=0.653)。两组间基因型频率差异无统计学意义(P<0.05)。
这些结果表明,在所研究的人群中,这些多态性与胆石症之间没有关联。